Showing results 1 to 20 of 102
next >
| Issue Date | Title | Author(s) |
| 2011 | A 3-DAY ORAL APREPITANT REGIMEN PROVIDES SUPERIOR PREVENTION OF CINV OVER STANDARD THERAPY IN CHINESE PATIENTS RECEIVING HIGH-DOSE CISPLATIN | Zhang, Li; Cheng, Ying; Zhang, Hong-Yu; Zhou, Caicun; Han, Baohui; Zhang, Yiping; Huang, Cheng; Chang, Jianhua; Song, Xiang Q.; Liang, Jun; Liang, Houjie; Bai, Chunxue; Yu, Shiying; Chen, Jia; Wang, Jie; Pan, Hongming; Carides, Alexandra; Chitkara, Denesh |
| 6-May-2023 | Agricultural development has not necessarily caused forest cover decline in semi-arid northern China over the past 12,000 years | Hao, Qian; Han, Yue; Liu, Hongyan; Cheng, Ying |
| 2015 | Axitinib versus sorafenib as a second-line therapy in Asian patients with metastatic renal cell carcinoma: results from a randomized registrational study | Qin, Shukui; Bi, Feng; Jin, Jie; Cheng, Ying; Guo, Jun; Ren, Xiubao; Huang, Yiran; Tarazi, Jamal; Tang, Jie; Chen, Connie; Kim, Sinil; Ye, Dingwei |
| 25-Oct-2022 | Bifunctional anti-PD-L1/TGF-beta RII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial | Liu, Dan; Zhou, Jun; Wang, Yongsheng; Li, Mingjun; Jiang, Haiping; Liu, Yunpeng; Yin, Xianli; Ge, Minghua; Xiang, Xiaojun; Ying, Jieer; Huang, Jian; Zhang, Yan-qiao; Cheng, Ying; Huang, Zhigang; Yuan, Xianglin; Han, Weiqing; Yan, Dong; Wang, Xinshuai; Liu, Pan; Wang, Linna; Zhang, Xiaojing; Luo, Suxia; Liu, Tianshu; Shen, Lin |
| 2019 | Camrelizumab combined with capecitabine and oxaliplatin followed by camrelizumab and apatinib as first-line therapy for advanced or metastatic gastric or gastroesophageal junction cancer: Updated results from a multicenter, open label phase II trial. | Shen, Lin; Peng, Zhi; Zhang, Yan-Qiao; Wei, Jia; Wang, Feng; Ying, Jieer; Deng, Yanhong; Gu, Kangsheng; Cheng, Ying; Yuan, Xianglin; Xiao, Juxiang; Wang, Linna; Zou, Jianjun |
| 1-Jun-2021 | Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction | Peng, Zhi; Wei, Jia; Wang, Feng; Ying, Jieer; Deng, Yanhong; Gu, Kangsheng; Cheng, Ying; Yuan, Xianglin; Xiao, Juxiang; Tai, Yanfei; Wang, Linna; Zou, Jianjun; Zhang, Yanqiao; Shen, Lin |
| 26-Nov-2024 | Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study | Zhou, Caicun; Chen, Gongyan; Huang, Yunchao; Zhou, Jianying; Lin, Lizhu; Feng, Jifeng; Wang, Zhehai; Shu, Yongqian; Shi, Jianhua; Hu, Yi; Wang, Qiming; Cheng, Ying; Wu, Fengying; Chen, Jianhua; Lin, Xiaoyan; Wang, Yongsheng; Huang, Jianan; Cui, Jiuwei; Cao, Lejie; Liu, Yunpeng; Zhang, Yiping; Pan, Yueyin; Zhao, Jun; Wang, Liping; Chang, Jianhua; Chen, Qun; Ren, Xiubao; Zhang, Wei; Fan, Yun; He, Zhiyong; Fang, Jian; Gu, Kangsheng; Dong, Xiaorong; Jin, Faguang; Gao, Hongjun; An, Guangyu; Ding, Cuimin; Jiang, Xiaodong; Xiong, Jianping; Zhou, Xiangdong; Hu, Sheng; Lu, Ping; Liu, Anwen; Guo, Shuliang; Huang, Jianjin; Zhu, Chengchu; Zhao, Jian; Gao, Beili; Chen, Yinglan; Hu, Chengping; Zhang, Jian; Zhang, Hongmei; Zhao, Hui; Wang, Zhigao; Ma, Xinjing; Shi, Wei |
| Mar-2021 | Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial | Zhou, Caicun; Chen, Gongyan; Huang, Yunchao; Zhou, Jianying; Lin, LiZhu; Feng, Jifeng; Wang, Zhehai; Shu, Yongqian; Shi, Jianhua; Hu, Yi; Wang, QiMing; Cheng, Ying; Wu, Fengying; Chen, Jianhua; Lin, Xiaoyan; Wang, Yongsheng; Huang, Jianan; Cui, Jiuwei; Cao, Lejie; Liu, Yunpeng; Zhang, Yiping; Pan, Yueyin; Zhao, Jun; Wang, LiPing; Chang, Jianhua; Chen, Qun; Ren, Xiubao; Zhang, Wei; Fan, Yun; He, Zhiyong; Fang, Jian; Gu, Kangsheng; Dong, XiaoRong; Zhang, Tao; Shi, Wei; Zou, Jianjun |
| Nov-2024 | Characteristics of Volatile Organic Compounds Emissions and Odor Impact in the Pharmaceutical Industry | Zhao, Hongchao; Cheng, Ying; Liu, Yanling; Wang, Xiuyan; Wang, Yuyan; Wang, Shuai; Jin, Taosheng |
| 2012 | Chinese guidelines on the diagnosis and treatment of primary lung cancer (2011) | Zhi, Xiu-yi; Wu, Yi-long; Bu, Hong; Cheng, Gang; Cheng, Ying; Du, Xiang; Han, Bao-hui; Jiang, Ge-ning; Jiao, Shun-chang; Liu, De-ruo; Liu, Lun-xu; Lu, You; Ma, Sheng-lin; Shi, Yuan-kai; Wang, Chang-li; Wang, Jie; Wang, Tian-you; Yang, Yue; Zhou, Qing-hua |
| 2013 | The Chinese subgroup from a randomized phase III study of lapatinib in combination with weekly paclitaxel versus weekly paclitaxel alone as second-line treatment of HER2-amplified advanced gastric cancer (AGC) in Asian countries | Sun, Guo-ping; Sun, Yan; Xu, Rui-hua; Xu, Jian-Ming; Li, Jin; Wang, Jin-Wan; Qin, Shukui; Feng, Ji Feng; Ba, Yi; Shen, Lin; Bai, Yu-Xian; Sun, Yihong; Pan, Hongming; Cheng, Ying; Yu, Shiying; Zhong, Haijun; Bai, Li; Luo, Rongcheng; Kobayashi, Mikiro; Ohtsu, Atsushi |
| Aug-2022 | Climate sustained the evolution of a stable postglacial woody cover over the Tibetan Plateau | Cheng, Ying; Liu, Hongyan; Han, Yue; Hao, Qian |
| Nov-2020 | Climate-Driven Holocene Migration of Forest-Steppe Ecotone in the Tien Mountains | Cheng, Ying; Liu, Hongyan; Wang, Hongya; Hao, Qian; Han, Yue; Duan, Keqin; Dong, Zhibao |
| 2019 | Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients | Zhang, Xu-Chao; Wang, Jun; Shao, Guo-Guang; Wang, Qun; Qu, Xiaotao; Wang, Bo; Moy, Christopher; Fan, Yue; Albertyn, Zayed; Huang, Xiayu; Zhang, Jingyu; Qiu, Yang; Platero, Suso; Lorenzi, Matthew V.; Zudaire, Enrique; Yang, Jennifer; Cheng, Ying; Xu, Lin; Wu, Yi-Long |
| 2018 | A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel | Wu, Yi-Long; Wang, Chang-Li; Liao, Mei-Lin; Guan, Zhong-Zhen; Gao, Chen-Yan; Lu, Shun; Zhao, Ming-Fang; Wang, Jie; Liu, Xiao-Qing; Yang, Jin-Ji; Liang, Jun; Mao, Wei-Min; Han, Bao-Hui; Zhang, Xu-Chao; Song, Yong; Feng, Ji-Feng; Ma, Sheng-Lin; Wu, Gang; Zhou, Cai-Cun; Chen, Ke-Neng; Cheng, Ying; He, Yong; Chen, Chun; Wang, Qun; Lin, Ji-Zhen; Zhu, Bo; Liu, Yun-Peng; Hu, Yi; Qiao, Gui-Bin; Zhou, Qing; Song, Qi-Bin; Wu, Nan; Wu, Lin; Huang, Cheng; Fu, Xiao-Long; Xiong, Jian-Ping; Hu, Jie; Hu, Cheng-Ping; Chang, Jian-Hua; Zhao, Qiong; Zhao, Jun; Zhou, |
| 2017 | A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel | Wu, Yi-Long; Wang, Chang-Li; Sun, Yan; Liao, Mei-Lin; Guan, Zhong-Zhen; Yang, Zhi-Min; Zhou, Qing-Hua; Lu, Shun; Cheng, Ying; Liu, Xiao-Qing; Zhang, Xu-Chao; Zhou, Caicun; Wang, Jie; Zhou, Qing; Song, Yong; Han, Bao-Hui; Ma, Zhi-Yong; Yang, Fan; Wang, Qun; Chuai, Shao-Kun; Shao, Yang; He, Wei; Zhu, Guanshan; Xiong, Lei; Wang, Jian-Jun; Chen, Ke-Neng; Zhang, Li; Mao, Wei-Min; Ma, Sheng-Lin; Feng, Ji-Feng; Yang, Xue-Ning; Xu, Lin; Chen, Gang; Zhao, Jian; Song, Qi-Bin; Shen-Tu, Yang; Qiao, Gui-Bin; Yu, Ding; Yu, Shi-Ying; Hu, Yi; Chen, Ming; Chen, Go |
| Dec-2024 | Consensus on the lung cancer management after third-generation EGFR-TKI resistance | Zhou, Qing; Zhao, Hongyun; Lu, Shun; Cheng, Ying; Liu, Ying; Zhao, Mingfang; Yu, Zhuang; Hu, Chengping; Zhang, Li; Yang, Fan; Zhao, Jun; Guo, Renhua; Ma, Rui; Du, Yingying; Dong, Xiaorong; Cui, Jiuwei; Tan, Daniel S. W.; Ahn, Myung-Ju; Tsuboi, Masahiro; Liu, Si-Yang Maggie; Mok, Tony S.; Wu, Yi-Long |
| 2017 | Contrasting effects of winter and summer climate on alpine timberline evolution in monsoon-dominated East Asia | Cheng, Ying; Liu, Hongyan; Wang, Hongya; Piao, Shilong; Yin, Yi; Ciais, Philippe; Wu, Xiuchen; Luo, Yao; Zhang, Caina; Song, Yaqiong; Gao, Yishen; Qiu, Anan |
| Aug-2022 | Contributions of climate, vegetation and soil to the alpine sediment carbon accumulation rate in central China since the Middle Holocene | Cheng, Ying; Liu, Hongyan; Wang, Hongya; Hao, Qian; Duan, Keqin; Dong, Zhibao |
| May-2024 | The crucial role of soil moisture in the evolution of forest cover in Asia since the Last Glacial Maximum | Cheng, Ying; Liu, Hongyan |
